Theoretical Implications and Roadmap Sample Clauses

Theoretical Implications and Roadmap. This construction is particularly relevant in the present state of Minimalist syntactic theory, as it presents an agreement configuration that is highly problematic to explain. The most salient problematic property is the fact that the complementizer agrees with a structurally higher noun phrase. The Agree relation is generally assumed to hold between a head and a goal which is c-commanded by the head, as part of a derivational structure which builds syntactic structures from the bottom (Xxxxxxx 2000, 2001). While there is some work proposing so-called ‘upward’ probing (e.g. Xxxxx 2008), as will be demonstrated in what follows, Lubukusu complementizer agreement diverges in important ways from the properties of Agree, even an upward-probing Agree. It is this core puzzle that occupies most of the focus of this paper. There are, however, additional theoretical puzzles raised by this construction. First, the complementizer agreement relationship in Lubukusu intersects in critical ways with phase theory. Note that while the head of CP is argued to be the edge of the phase and accessible to higher operations (Xxxxxxx 2008, among others), the verb in
Sample 1
AutoNDA by SimpleDocs
Theoretical Implications and Roadmap. This construction is particularly relevant in the present state of Minimalist syntactic theory, as it presents an agreement configuration that is highly problematic to explain. The most salient problematic property is the fact that the complementizer agrees with a structurally higher noun phrase. The Agree relation is generally assumed to hold between a head and a goal which is c-commanded by the head, as part of a derivational structure which builds syntactic structures from the bottom up (Xxxxxxx 2000, 2001). While there is some work proposing so-called ‘upward’ probing (x.x. Xxxxx 2008), as will be demonstrated in what follows, Xxxxxxxx 1 Lubukusu has been reclassified from its Xxxxxxx classification of E31c to J30 in Xxxxx (2009), and JE31c in Maho (2008). 2 It is often said that Lubukusu is a dialect of Luyia, but the Ethnologue’s terminology recognizes that there is no standard “Luyia” language, but rather, each Luyia speaker speaks one of its varieties. There are estimated to be 17- 23 Luyia languages, all with varying degrees of mutual intelligibility (Xxxxx 2009, Xxxxx 2009).
Sample 1

Related to Theoretical Implications and Roadmap

  • Tax Implications Without limitation, we do not accept liability for any adverse tax implications of any Transaction whatsoever.

  • FINANCIAL IMPLICATIONS There are no budget implications. The applicant will be responsible for all costs, expenses, liabilities and obligations imposed under or incurred in order to satisfy the terms of this proposed development agreement. The administration of the proposed development agreement can be carried out within the approved 2019- 2020 budget and with existing resources.

  • Service Providing Methodology 1.3.1 Party A and Party B agree that during the term of this Agreement, where necessary, Party B may enter into further service agreements with Party A or any other party designated by Party A, which shall provide the specific contents, manner, personnel, and fees for the specific services.

  • Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company, that are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, and are intended to be submitted to FDA or other comparable government entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder and for studies submitted to regulatory authorities for approval, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate and complete in all material respects and fairly present the data derived from such studies and trials; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies or trials, the results of which the Company believes reasonably call into question the study or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or written correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

  • Return of Materials at Termination In the event of any termination or cessation of his employment with Employer for any reason, Employee shall promptly deliver to Employer all documents, data and other information derived from or otherwise pertaining to Confidential Information. Employee shall not take or retain any documents or other information, or any reproduction or excerpt thereof, containing any Confidential Information.

  • Investment Analysis and Implementation In carrying out its obligations under Section 1 hereof, the Advisor shall:

  • SERVICE MONITORING, ANALYSES AND ORACLE SOFTWARE 11.1 We continuously monitor the Services to facilitate Oracle’s operation of the Services; to help resolve Your service requests; to detect and address threats to the functionality, security, integrity, and availability of the Services as well as any content, data, or applications in the Services; and to detect and address illegal acts or violations of the Acceptable Use Policy. Oracle monitoring tools do not collect or store any of Your Content residing in the Services, except as needed for such purposes. Oracle does not monitor, and does not address issues with, non-Oracle software provided by You or any of Your Users that is stored in, or run on or through, the Services. Information collected by Oracle monitoring tools (excluding Your Content) may also be used to assist in managing Oracle’s product and service portfolio, to help Oracle address deficiencies in its product and service offerings, and for license management purposes.

  • Product Quality 4.1 The following provisions shall apply to Product after Production:

  • Technical Feasibility of String While ICANN has encouraged and will continue to encourage universal acceptance of all top-­‐level domain strings across the Internet, certain top-­‐level domain strings may encounter difficulty in acceptance by ISPs and webhosters and/or validation by web applications. Registry Operator shall be responsible for ensuring to its satisfaction the technical feasibility of the TLD string prior to entering into this Agreement.

  • TECHNICAL EVALUATION (a) Detailed technical evaluation shall be carried out by Purchase Committee pursuant to conditions in the tender document to determine the substantial responsiveness of each tender. For this clause, the substantially responsive bid is one that conforms to all the eligibility and terms and condition of the tender without any material deviation. The Institute’s determination of bid’s responsiveness is to be based on the contents of the bid itself without recourse to extrinsic evidence. The Institute shall evaluate the technical bids also to determine whether they are complete, whether required sureties have been furnished, whether the documents have been properly signed and whether the bids are in order.

Time is Money Join Law Insider Premium to draft better contracts faster.